CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+8.11%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.55B
AUM Growth
+$2.55B
(+1.1%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-5.41%
Top 10 Holdings %
Top 10 Hldgs %
53.61%
Holding
38
New
4
Increased
11
Reduced
7
Closed
5
Top Buys
| 1 |
Sanofi
SNY
|
$118M |
| 2 |
Cardinal Health
CAH
|
$71.4M |
| 3 |
The Beauty Health Co
SKIN
|
$67.2M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$44.4M |
| 5 |
Hologic
HOLX
|
$44.4M |
Top Sells
| 1 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$205M |
| 2 |
Zimmer Biomet
ZBH
|
$100M |
| 3 |
Universal Health Services
UHS
|
$91.5M |
| 4 |
Welltower
WELL
|
$58M |
| 5 |
Ventas
VTR
|
$48M |
Sector Composition
| 1 | Healthcare | 94.16% |
| 2 | Consumer Staples | 2.64% |
| 3 | Technology | 2.13% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tenet Healthcare
THC
$16.3B
| $191M | 6.43% | 2,850,000 -150,000 | -5% | -$10M |
|
|
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
| $184M | 6.2% | 3,500,000 -250,000 | -7% | -$13.2M |
|
3
Viatris
VTRS
$12.3B
| $171M | 5.78% | 12,000,000 | – | – |
|
4
HCA Healthcare
HCA
$94.5B
| $124M | 4.18% | 600,000 -175,000 | -23% | -$36.2M |
|
5
Brookdale Senior Living
BKD
$1.83B
| $121M | 4.09% | 15,350,000 +2,850,000 | +23% | +$22.5M |
|
|
6
Sanofi
SNY
$121B
| $118M | 3.99% | +2,250,000 | New | +$118M |
|
7
Merck
MRK
$210B
| $117M | 3.93% | 1,500,000 +500,000 | +50% | +$38.9M |
|
8
Perrigo
PRGO
$3.27B
| $115M | 3.86% | 2,500,000 -300,000 | -11% | -$13.8M |
|
|
9
Universal Health Services
UHS
$11.6B
| $113M | 3.82% | 775,000 -625,000 | -45% | -$91.5M |
|
10
GSK
GSK
$79.9B
| $110M | 3.69% | 2,750,000 +250,000 | +10% | +$9.96M |
|
11
Alkermes
ALKS
$4.78B
| $105M | 3.55% | 4,300,000 -1,300,000 | -23% | -$31.9M |
|
12
Ironwood Pharmaceuticals
IRWD
$214M
| $96.5M | 3.25% | 7,500,000 | – | – |
|
13
Gilead Sciences
GILD
$140B
| $96.4M | 3.25% | 1,400,000 +400,000 | +40% | +$27.5M |
|
14
Myriad Genetics
MYGN
$593M
| $91.7M | 3.09% | 3,000,000 | – | – |
|
15
Ionis Pharmaceuticals
IONS
$6.79B
| $79.8M | 2.69% | 2,000,000 +1,000,000 | +100% | +$39.9M |
|
|
16
Cardinal Health
CAH
$35.5B
| $71.4M | 2.4% | +1,250,000 | New | +$71.4M |
|
|
17
The Beauty Health Co
SKIN
$264M
| $67.2M | 2.26% | +4,000,000 | New | +$67.2M |
|
|
RETA
18
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $65.8M | 2.22% | 465,000 +65,000 | +16% | +$9.2M |
|
|
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $64.6M | 2.18% | 400,000 +275,000 | +220% | +$44.4M |
|
20
Nektar Therapeutics
NKTR
$568M
| $60.1M | 2.02% | 3,500,000 +1,500,000 | +75% | +$25.7M |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $54.5M | 1.83% | 5,500,000 | – | – |
|
|
CHNG
22
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $54.1M | 1.82% | 2,350,000 -8,900,000 | -79% | -$205M |
|
23
Collegium Pharmaceutical
COLL
$1.22B
| $47.3M | 1.59% | 2,000,000 | – | – |
|
|
24
Hologic
HOLX
$14.9B
| $44.4M | 1.49% | +665,000 | New | +$44.4M |
|
|
TBIO
25
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $38.6M | 1.3% | 1,400,000 +250,000 | +22% | +$6.89M |
|